Aurintricarboxylic acid

Aurintricarboxylic acid is an inhibitor of P2 Receptors and Topoisomerase used in studies of Immune Signaling and DNA Damage Response and related signaling programs. In practice, this places the compound in experiments that measure cytokine-mediated signaling and inflammatory effector responses and checkpoint activation, DNA repair, and genome-stability control in apoptosis, cancer, and dna damage / repair models.

By inhibiting P2 Receptors and Topoisomerase, Aurintricarboxylic acid can be used to examine cytokine-mediated signaling and inflammatory effector responses and checkpoint activation, DNA repair, and genome-stability control. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and dna damage / repair models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving P2 Receptors and Topoisomerase
• Pathway perturbation studies connected to Immune Signaling and DNA Damage Response and related signaling programs
• Concentration-response inhibition and target-dependence studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, Aurintricarboxylic acid is appropriate when a defined chemical perturbant is needed to connect P2 Receptors and Topoisomerase with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and dna damage / repair models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.